| 000 | 01820 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250517162403.0 | ||
| 264 | 0 | _c20171101 | |
| 008 | 201711s 0 0 eng d | ||
| 022 | _a1420-9071 | ||
| 024 | 7 |
_a10.1007/s00018-017-2583-0 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMoulin, Morgane | |
| 245 | 0 | 0 |
_aVγ9Vδ2 T cell activation by strongly agonistic nucleotidic phosphoantigens. _h[electronic resource] |
| 260 |
_bCellular and molecular life sciences : CMLS _c12 2017 |
||
| 300 |
_a4353-4367 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAdenosine Triphosphate _xanalogs & derivatives |
| 650 | 0 | 4 |
_aAntigens _xpharmacology |
| 650 | 0 | 4 |
_aAntigens, CD _xgenetics |
| 650 | 0 | 4 |
_aButyrophilins _xgenetics |
| 650 | 0 | 4 | _aDose-Response Relationship, Immunologic |
| 650 | 0 | 4 | _aHeLa Cells |
| 650 | 0 | 4 |
_aHemiterpenes _xpharmacology |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aInterferon-gamma _xbiosynthesis |
| 650 | 0 | 4 | _aK562 Cells |
| 650 | 0 | 4 |
_aLymphocyte Activation _xdrug effects |
| 650 | 0 | 4 |
_aLysosomal-Associated Membrane Protein 1 _xbiosynthesis |
| 650 | 0 | 4 |
_aOrganophosphates _xpharmacology |
| 650 | 0 | 4 |
_aOrganophosphorus Compounds _xpharmacology |
| 650 | 0 | 4 | _aPrimary Cell Culture |
| 650 | 0 | 4 |
_aReceptors, Antigen, T-Cell, gamma-delta _xclassification |
| 650 | 0 | 4 |
_aT-Lymphocytes _xcytology |
| 650 | 0 | 4 |
_aTumor Necrosis Factor-alpha _xbiosynthesis |
| 700 | 1 | _aAlguacil, Javier | |
| 700 | 1 | _aGu, Siyi | |
| 700 | 1 | _aMehtougui, Asmaa | |
| 700 | 1 | _aAdams, Erin J | |
| 700 | 1 | _aPeyrottes, Suzanne | |
| 700 | 1 | _aChampagne, Eric | |
| 773 | 0 |
_tCellular and molecular life sciences : CMLS _gvol. 74 _gno. 23 _gp. 4353-4367 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/s00018-017-2583-0 _zAvailable from publisher's website |
| 999 |
_c27330409 _d27330409 |
||